Exponent (NASDAQ:EXPO) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, BidAskClub reports.

EXPO has been the topic of a number of other reports. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research note on Tuesday, March 3rd. Sidoti upgraded shares of Exponent from a “neutral” rating to a “buy” rating and set a $80.00 target price for the company in a research note on Wednesday, May 13th. Cantor Fitzgerald raised their target price on shares of Exponent from $75.00 to $84.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Finally, Zacks Investment Research downgraded shares of Exponent from a “buy” rating to a “hold” rating in a research note on Wednesday, April 8th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Exponent has an average rating of “Buy” and an average target price of $83.25.

Shares of NASDAQ EXPO traded up $0.75 during midday trading on Thursday, reaching $69.43. 265,724 shares of the company’s stock traded hands, compared to its average volume of 288,447. The company has a quick ratio of 3.81, a current ratio of 3.81 and a debt-to-equity ratio of 0.05. The stock’s 50 day simple moving average is $68.82 and its 200-day simple moving average is $69.56. Exponent has a one year low of $55.08 and a one year high of $82.82. The company has a market cap of $3.54 billion, a price-to-earnings ratio of 43.39 and a beta of 0.24.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, April 30th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.42 by $0.07. Exponent had a net margin of 20.28% and a return on equity of 25.03%. The firm had revenue of $99.70 million for the quarter, compared to the consensus estimate of $101.21 million. During the same period last year, the firm earned $0.42 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Equities analysts predict that Exponent will post 1.33 EPS for the current fiscal year.

In other news, VP Bradley A. James sold 4,370 shares of Exponent stock in a transaction on Monday, May 18th. The shares were sold at an average price of $67.56, for a total transaction of $295,237.20. Following the completion of the sale, the vice president now directly owns 3,120 shares in the company, valued at $210,787.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.20% of the company’s stock.

Several large investors have recently bought and sold shares of EXPO. Archer Investment Corp acquired a new stake in shares of Exponent during the fourth quarter worth $33,000. Synovus Financial Corp lifted its stake in shares of Exponent by 1,333.3% during the first quarter. Synovus Financial Corp now owns 645 shares of the business services provider’s stock worth $46,000 after buying an additional 600 shares during the period. Fieldpoint Private Securities LLC lifted its stake in shares of Exponent by 74.4% during the fourth quarter. Fieldpoint Private Securities LLC now owns 736 shares of the business services provider’s stock worth $51,000 after buying an additional 314 shares during the period. Parkside Financial Bank & Trust raised its holdings in shares of Exponent by 889.7% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,346 shares of the business services provider’s stock worth $93,000 after purchasing an additional 1,210 shares during the last quarter. Finally, Ballast Advisors LLC purchased a new position in shares of Exponent during the first quarter worth $99,000. Institutional investors and hedge funds own 86.72% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Further Reading: Limitations of the P/E Growth ratio

Analyst Recommendations for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.